| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69448-016-11 | 69448-016 | HUMAN PRESCRIPTION DRUG | HERCESSI | trastuzumab-strf | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20250101 | N/A | BLA | BLA761346 | Accord BioPharma Inc. | TRASTUZUMAB | 420 mg/20mL | 1 VIAL, MULTI-DOSE in 1 CARTON (69448-016-11) / 20 mL in 1 VIAL, MULTI-DOSE |
| 69448-015-05 | 69448-015 | HUMAN PRESCRIPTION DRUG | HERCESSI | trastuzumab-strf | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20250101 | N/A | BLA | BLA761346 | Accord BioPharma Inc. | TRASTUZUMAB | 150 mg/7.4mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (69448-015-05) / 7.4 mL in 1 VIAL, SINGLE-DOSE |